To help you make the best choice at the grocery store, learn key differences between grass-fed and regular butter, including ...

EQT Life Sciences is pleased to announce that its LSP Dementia Fund has co-led a EUR 51 million Series B in Exciva (the "Company"), a clinical-stage biopharmaceutical company developing novel ...

Strong late-game efforts from the Gamecocks' biggest contributors paved the way for women's basketball's biggest win of the ...

Columnist Jim Abrams write about the nutritional benefits of wild game, its low carbon footprint and the physical rewards of ...

If you’re looking to create a healthier lifestyle, look no further than the power of running. Movement makes up a portion of the weight loss puzzle, and with our new Running for Weight Loss program, ...

Forbes contributors publish independent expert analyses and insights. Across the earlier articles in this series, we developed a framework for understanding why weight loss and regulation is far more ...

If you’re ready to change your life but don’t know where to begin, Running for Weight Loss offers a clear, supportive path forward. Guided by experts, you’ll learn how metabolism works, understand ...

California will end Medi-Cal coverage for popular weight-loss drugs like Wegovy starting Jan. 1, citing soaring pharmaceutical costs. Low-income residents losing coverage will be advised to rely on ...

Lauren Ball receives funding from the National Health and Medical Research Council, Health and Wellbeing Queensland, Heart Foundation, Gallipoli Medical Research and Mater Health, Springfield City ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...